T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.97B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.37B |
| 3 |
lululemon athletica
LULU
|
+$1.32B |
| 4 |
Spotify
SPOT
|
+$1.28B |
| 5 |
ServiceNow
NOW
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.41B |
| 2 |
Northrop Grumman
NOC
|
+$2.36B |
| 3 |
Microsoft
MSFT
|
+$2.2B |
| 4 |
McDonald's
MCD
|
+$1.85B |
| 5 |
Intercontinental Exchange
ICE
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 12.98% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CareTrust REIT
CTRE
$9.18B
| $1.66M | ﹤0.01% |
80,212
+17,388
| +28% | +$380K |
|
|
VRE
1677
DELISTED
Veris Residential
VRE
| $1.65M | ﹤0.01% |
71,206
+3,445
| +5% | +$74.7K |
|
1678
Extreme Networks
EXTR
$3.16B
| $1.64M | ﹤0.01% |
222,241
+97,101
| +78% | +$681K |
|
1679
Coherent
COHR
$64B
| $1.63M | ﹤0.01% |
48,516
+4,843
| +11% | +$154K |
|
|
PTLA
1680
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.63M | ﹤0.01% |
68,306
+15,764
| +30% | +$435K |
|
1681
FNB Corp
FNB
$6.88B
| $1.61M | ﹤0.01% |
127,091
+10,311
| +9% | +$126K |
|
1682
Medifast
MED
$128M
| $1.61M | ﹤0.01% |
14,721
+434
| +3% | +$42K |
|
|
VAL
1683
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $1.61M | ﹤0.01% |
245,409
-77,686
| -24% | -$379K |
|
1684
CBIZ
CBZ
$2.96B
| $1.61M | ﹤0.01% |
59,566
+2,038
| +4% | +$53K |
|
1685
Terex
TEX
$7.57B
| $1.59M | ﹤0.01% |
53,549
+6,113
| +13% | +$172K |
|
|
SC
1686
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.59M | ﹤0.01% |
68,075
+3,055
| +5% | +$74.2K |
|
1687
OraSure Technologies
OSUR
$277M
| $1.59M | ﹤0.01% |
197,750
+57,337
| +41% | +$463K |
|
1688
Associated Banc-Corp
ASB
$6.07B
| $1.59M | ﹤0.01% |
72,027
-6,539
| -8% | -$138K |
|
|
SF
1689
Stifel
SF
$12.9B
| $1.59M | ﹤0.01% |
58,835
+5,848
| +11% | +$153K |
|
1690
S&T Bancorp
STBA
$1.82B
| $1.58M | ﹤0.01% |
39,297
+6,006
| +18% | +$227K |
|
1691
iShares MSCI Japan ETF
EWJ
$23.2B
| $1.58M | ﹤0.01% |
26,625
+7,600
| +40% | +$448K |
|
1692
Atlantic Union Bankshares
AUB
$6.09B
| $1.57M | ﹤0.01% |
41,767
+3,538
| +9% | +$133K |
|
1693
Neogen
NEOG
$2.59B
| $1.56M | ﹤0.01% |
47,900
+9,066
| +23% | +$298K |
|
1694
Outfront Media
OUT
$5.24B
| $1.56M | ﹤0.01% |
59,123
-7,709
| -12% | -$198K |
|
|
TGNA
1695
DELISTED
TEGNA Inc
TGNA
| $1.56M | ﹤0.01% |
93,232
+8,626
| +10% | +$134K |
|
|
AVTA
1696
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.55M | ﹤0.01% |
59,469
-5,091
| -8% | -$114K |
|
|
MNR
1697
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.54M | ﹤0.01% |
106,512
-26,304
| -20% | -$389K |
|
1698
Hancock Whitney
HWC
$6.37B
| $1.54M | ﹤0.01% |
35,036
+3,361
| +11% | +$136K |
|
1699
Lithia Motors
LAD
$8.32B
| $1.53M | ﹤0.01% |
10,415
+895
| +9% | +$134K |
|
|
BCPC
1700
Balchem Corp
BCPC
$5.65B
| $1.52M | ﹤0.01% |
14,982
-110,577
| -88% | -$11.2M |
|
Similar funds
T. Rowe Price Associates's Q4 2019 Portfolio in Review
As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
- T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
- T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
- T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
- T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
- T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
- T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.
Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.